CN107582984A - A kind of pharmaceutical composition for treating cancer of the esophagus - Google Patents
A kind of pharmaceutical composition for treating cancer of the esophagus Download PDFInfo
- Publication number
- CN107582984A CN107582984A CN201710997054.3A CN201710997054A CN107582984A CN 107582984 A CN107582984 A CN 107582984A CN 201710997054 A CN201710997054 A CN 201710997054A CN 107582984 A CN107582984 A CN 107582984A
- Authority
- CN
- China
- Prior art keywords
- parts
- root
- chinese
- esophagus
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000017897 Carcinoma of esophagus Diseases 0.000 title claims abstract description 17
- 208000000461 Esophageal Neoplasms Diseases 0.000 title claims abstract description 17
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 13
- ZOMNIUBKTOKEHS-UHFFFAOYSA-L dimercury dichloride Chemical compound Cl[Hg][Hg]Cl ZOMNIUBKTOKEHS-UHFFFAOYSA-L 0.000 claims abstract description 20
- 241001412627 Adenophora liliifolia Species 0.000 claims abstract description 10
- 241001233914 Chelidonium majus Species 0.000 claims abstract description 10
- 241000601164 Clematis orientalis Species 0.000 claims abstract description 10
- 240000005717 Dioscorea alata Species 0.000 claims abstract description 10
- 244000169544 Duchesnea indica Species 0.000 claims abstract description 10
- 241000594394 Hedyotis Species 0.000 claims abstract description 10
- 244000153234 Hibiscus abelmoschus Species 0.000 claims abstract description 10
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims abstract description 10
- 244000241872 Lycium chinense Species 0.000 claims abstract description 10
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 10
- 241000623906 Lytta vesicatoria Species 0.000 claims abstract description 10
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 10
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 10
- 240000007164 Salvia officinalis Species 0.000 claims abstract description 10
- 235000000336 Solanum dulcamara Nutrition 0.000 claims abstract description 10
- 240000001417 Vigna umbellata Species 0.000 claims abstract description 10
- 235000011453 Vigna umbellata Nutrition 0.000 claims abstract description 10
- 229940075397 calomel Drugs 0.000 claims abstract description 10
- 235000005412 red sage Nutrition 0.000 claims abstract description 10
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 9
- 235000014375 Curcuma Nutrition 0.000 claims abstract description 9
- 244000164480 Curcuma aromatica Species 0.000 claims abstract description 9
- 240000009138 Curcuma zedoaria Species 0.000 claims abstract description 9
- 235000003405 Curcuma zedoaria Nutrition 0.000 claims abstract description 9
- 235000002594 Solanum nigrum Nutrition 0.000 claims abstract description 9
- 240000002307 Solanum ptychanthum Species 0.000 claims abstract description 9
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 claims abstract description 9
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims abstract description 9
- 235000019509 white turmeric Nutrition 0.000 claims abstract description 9
- 241000193241 Solanum dulcamara Species 0.000 claims abstract 4
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims 1
- 244000178320 Vaccaria pyramidata Species 0.000 claims 1
- 235000010587 Vaccaria pyramidata Nutrition 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 229910052709 silver Inorganic materials 0.000 claims 1
- 239000004332 silver Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 3
- 208000024891 symptom Diseases 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 description 10
- 201000011510 cancer Diseases 0.000 description 9
- 241000208365 Celastraceae Species 0.000 description 6
- 208000001154 Dermoid Cyst Diseases 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 210000003238 esophagus Anatomy 0.000 description 3
- 210000004907 gland Anatomy 0.000 description 3
- 239000000203 mixture Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000004768 organ dysfunction Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Abstract
The invention discloses a kind of pharmaceutical composition for treating cancer of the esophagus.Described pharmaceutical composition by following weight than bulk drug form：15 18 parts of radix bupleuri, 15 18 parts of honeysuckle flower, 15 18 parts of rattletop; 15 18 parts of the root of straight ladybell, 15 18 parts of mock-strawberry, 15 18 parts of paniculate swallowwort; 15 18 parts of the root of Chinese clematis, 15 18 parts of pollen, 15 18 parts of the red sage root; 15 18 parts of Rhizoma Sparganii, 15 18 parts of first pearl, 15 18 parts of airpotato yam; 15 18 parts of red bean root, 15 18 parts of curcuma zedoary, 15 18 parts of calculus bovis factitius; 15 18 parts of Moschus; 15 18 parts of the root bark of Chinese wolf-berry, 15 18 parts of HERBA HEDYOTIS DIFFUSAE, 15 18 parts of Sculellaria barbata; 15 18 parts of Chinese blister beetle; 15 18 parts of pseudo-ginseng, 15 18 parts of black nightshade, 15 18 parts of bittersweet; 15 18 parts of indigo naturalis, 15 18 parts of calomel mercurous chloride.The present invention can effectively alleviate the symptom of cancer of the esophagus.
Description
Technical field
The present invention relates to Chinese medicine formulation art, especially a kind of pharmaceutical composition for treating cancer of the esophagus.
Background technology
Cancer of the esophagus is the tumour in the epithelial source for betiding esophagus.Histologically classification is epithelium
The dermoid cancer of canceration and the gland cancer of esophageal gland canceration.In Japan, dermoid cancer accounts for cancer of the esophagus entirety
90%, remaining 5% is gland cancer.It was found from this, Japanese cancer of the esophagus is substantially dermoid cancer.Moreover, it is mainly in
The male of more than 60 years old, men and women's ratio are 3~5:1.Because there is no outer membrane (serous coat), the cancer of propagation as the morphologic feature of esophagus
Cell easily to surrounding wetting, is also easily transferred to lymph node, so the progress of canceration is fast.Plus due to lack subjective symptom,
Thus early detection easily postpones.The prognosis of cancer of the esophagus extreme difference, esophagus in the Alimentary System including stomach cancer, colorectal cancer
5 overall annual survival rates of cancer are 14% or so.
The content of the invention
For above-mentioned deficiency, the present invention is intended to provide a kind of pharmaceutical composition that can effectively treat cancer of the esophagus.
In order to realize above-mentioned technique effect, technical scheme provided by the invention is such：A kind of medicine for treating cancer of the esophagus
Compositions, including following parts by weight of component：Radix bupleuri 15-18 parts, honeysuckle flower 15-18 parts, rattletop 15-18 parts, the root of straight ladybell 15-18 parts,
Mock-strawberry 15-18 parts, paniculate swallowwort 15-18 parts, root of Chinese clematis 15-18 parts, pollen 15-18 parts, red sage root 15-18 parts, Rhizoma Sparganii 15-18 parts,
First pearl 15-18 parts, airpotato yam 15-18 parts, red bean root 15-18 parts, curcuma zedoary 15-18 parts, calculus bovis factitius 15-18 parts, Moschus 15-18
Part, root bark of Chinese wolf-berry 15-18 parts, HERBA HEDYOTIS DIFFUSAE 15-18 parts, Sculellaria barbata 15-18 parts, Chinese blister beetle 15-18 parts, pseudo-ginseng 15-18 parts, black nightshade 15-
18 parts, bittersweet 15-18 parts, indigo naturalis 15-18 parts, calomel mercurous chloride 15-18 parts.
Preferably, including following parts by weight of component, radix bupleuri 15-17 parts, honeysuckle flower 15-17 parts, rattletop 15-17 parts, the root of straight ladybell 15-
17 parts, mock-strawberry 15-17 parts, paniculate swallowwort 15-17 parts, root of Chinese clematis 15-17 parts, pollen 15-17 parts, red sage root 15-17 parts, Rhizoma Sparganii 15-
17 parts, first pearl 15-17 parts, airpotato yam 15-17 parts, red bean root 15-17 parts, curcuma zedoary 15-17 parts, calculus bovis factitius 15-17 parts, Moschus
15-17 parts, root bark of Chinese wolf-berry 15-17 parts, HERBA HEDYOTIS DIFFUSAE 15-17 parts, Sculellaria barbata 15-17 parts, Chinese blister beetle 15-17 parts, pseudo-ginseng 15-17 parts, dragon
Certain herbaceous plants with big flowers 15-17 parts, bittersweet 15-17 parts, indigo naturalis 15-17 parts, calomel mercurous chloride 15-17 parts.
Optimal, including following parts by weight of component, 16 parts of radix bupleuri, 16 parts of honeysuckle flower, 16 parts of rattletop, 16 parts of the root of straight ladybell, mock-strawberry 16
Part, 16 parts of paniculate swallowwort, 16 parts of the root of Chinese clematis, 16 parts of pollen, 16 parts of the red sage root, 16 parts of Rhizoma Sparganii, 16 parts of first pearl, 16 parts of airpotato yam, red bean
16 parts of root, 16 parts of curcuma zedoary, 16 parts of calculus bovis factitius, 16 parts of Moschus, 16 parts of the root bark of Chinese wolf-berry, 16 parts of HERBA HEDYOTIS DIFFUSAE, 16 parts of Sculellaria barbata, Chinese blister beetle 16
Part, 16 parts of pseudo-ginseng, 16 parts of black nightshade, 16 parts of bittersweet, 16 parts of indigo naturalis, 16 parts of calomel mercurous chloride.
Pharmaceutical composition of the present invention have capable, clearing heat and detoxicating, the dampness elimination apocenosis of invigorating blood circulation, broken knurl dispel product, anticancer sterilize,
Dispel saprophytic purulence and other effects, while cancer cell can be suppressed and invade profit tissue, strengthen immunity, suppress the multiple thing growth diffusion of cancer cell,
To balance the eubolism of each organ dysfunction.
Embodiment
With reference to embodiment, the claim of the present invention is described in further detail, but not formed pair
Any restrictions of the present invention, any limited number of time modification made in the claims in the present invention protection domain, still the present invention's
In claims.
Embodiment 1
A kind of pharmaceutical composition for treating cancer of the esophagus, including following parts by weight of component：15 parts of radix bupleuri, 18 parts of honeysuckle flower, rattletop
15 parts, 18 parts of the root of straight ladybell, 15 parts of mock-strawberry, 18 parts of paniculate swallowwort, 15 parts of the root of Chinese clematis, 18 parts of pollen, 15 parts of the red sage root, 18 parts of Rhizoma Sparganii, first pearl
15 parts, 18 parts of airpotato yam, 15 parts of red bean root, 18 parts of curcuma zedoary, 15 parts of calculus bovis factitius, 18 parts of Moschus, 15 parts of the root bark of Chinese wolf-berry, HERBA HEDYOTIS DIFFUSAE 18
Part, 15 parts of Sculellaria barbata, 18 parts of Chinese blister beetle, 18 parts of pseudo-ginseng, 18 parts of black nightshade, 15 parts of bittersweet, 15 parts of indigo naturalis, 18 parts of calomel mercurous chloride.
Embodiment 2
A kind of pharmaceutical composition for treating cancer of the esophagus, including following parts by weight of component, 15 parts of radix bupleuri, 17 parts of honeysuckle flower, rattletop
15 parts, 17 parts of the root of straight ladybell, 15 parts of mock-strawberry, 17 parts of paniculate swallowwort, 15 parts of the root of Chinese clematis, 17 parts of pollen, 15 parts of the red sage root, 17 parts of Rhizoma Sparganii, first pearl
15 parts, 17 parts of airpotato yam, 15 parts of red bean root, 17 parts of curcuma zedoary, 15 parts of calculus bovis factitius, 17 parts of Moschus, 15 parts of the root bark of Chinese wolf-berry, HERBA HEDYOTIS DIFFUSAE 17
Part, 15 parts of Sculellaria barbata, 17 parts of Chinese blister beetle, 17 parts of pseudo-ginseng, 17 parts of black nightshade, 15 parts of bittersweet, 15 parts of indigo naturalis, 17 parts of calomel mercurous chloride.
Embodiment 3
A kind of pharmaceutical composition for treating cancer of the esophagus, including following parts by weight of component, 16 parts of radix bupleuri, 16 parts of honeysuckle flower, rattletop
16 parts, 16 parts of the root of straight ladybell, 16 parts of mock-strawberry, 16 parts of paniculate swallowwort, 16 parts of the root of Chinese clematis, 16 parts of pollen, 16 parts of the red sage root, 16 parts of Rhizoma Sparganii, first pearl
16 parts, 16 parts of airpotato yam, 16 parts of red bean root, 16 parts of curcuma zedoary, 16 parts of calculus bovis factitius, 16 parts of Moschus, 16 parts of the root bark of Chinese wolf-berry, HERBA HEDYOTIS DIFFUSAE 16
Part, 16 parts of Sculellaria barbata, 16 parts of Chinese blister beetle, 16 parts of pseudo-ginseng, 16 parts of black nightshade, 16 parts of bittersweet, 16 parts of indigo naturalis, 16 parts of calomel mercurous chloride.
Above-described is only presently preferred embodiments of the present invention, all timess done in the range of the spirit and principles in the present invention
What modifications, equivalent substitutions and improvements etc., should be included within the scope of the present invention.
Claims (3)
1. a kind of pharmaceutical composition for treating cancer of the esophagus, it is characterised in that including following parts by weight of component：Radix bupleuri 15-18 parts, silver
Flower 15-18 parts, rattletop 15-18 parts, the root of straight ladybell 15-18 parts, mock-strawberry 15-18 parts, paniculate swallowwort 15-18 parts, root of Chinese clematis 15-18 parts, flower
Powder 15-18 parts, red sage root 15-18 parts, Rhizoma Sparganii 15-18 parts, first pearl 15-18 parts, airpotato yam 15-18 parts, red bean root 15-18 parts, cowherb
Art 15-18 parts, calculus bovis factitius 15-18 parts, Moschus 15-18 parts, root bark of Chinese wolf-berry 15-18 parts, HERBA HEDYOTIS DIFFUSAE 15-18 parts, Sculellaria barbata 15-18
Part, Chinese blister beetle 15-18 parts, pseudo-ginseng 15-18 parts, black nightshade 15-18 parts, bittersweet 15-18 parts, indigo naturalis 15-18 parts, calomel mercurous chloride 15-18 parts.
2. a kind of pharmaceutical composition for treating cancer of the esophagus according to claim 1, it is characterised in that including following parts by weight
Component, radix bupleuri 15-17 parts, honeysuckle flower 15-17 parts, rattletop 15-17 parts, the root of straight ladybell 15-17 parts, mock-strawberry 15-17 parts, paniculate swallowwort 15-17
Part, root of Chinese clematis 15-17 parts, pollen 15-17 parts, red sage root 15-17 parts, Rhizoma Sparganii 15-17 parts, first pearl 15-17 parts, airpotato yam 15-17
Part, red bean root 15-17 parts, curcuma zedoary 15-17 parts, calculus bovis factitius 15-17 parts, Moschus 15-17 parts, root bark of Chinese wolf-berry 15-17 parts, HERBA HEDYOTIS DIFFUSAE
15-17 parts, Sculellaria barbata 15-17 parts, Chinese blister beetle 15-17 parts, pseudo-ginseng 15-17 parts, black nightshade 15-17 parts, bittersweet 15-17 parts, indigo naturalis 15-
17 parts, calomel mercurous chloride 15-17 parts.
3. a kind of pharmaceutical composition for treating cancer of the esophagus according to claim 1, it is characterised in that including following parts by weight
Component, 16 parts of radix bupleuri, 16 parts of honeysuckle flower, 16 parts of rattletop, 16 parts of the root of straight ladybell, 16 parts of mock-strawberry, 16 parts of paniculate swallowwort, 16 parts of the root of Chinese clematis, pollen
16 parts, 16 parts of the red sage root, 16 parts of Rhizoma Sparganii, 16 parts of first pearl, 16 parts of airpotato yam, 16 parts of red bean root, 16 parts of curcuma zedoary, 16 parts of calculus bovis factitius,
16 parts of Moschus, 16 parts of the root bark of Chinese wolf-berry, 16 parts of HERBA HEDYOTIS DIFFUSAE, 16 parts of Sculellaria barbata, 16 parts of Chinese blister beetle, 16 parts of pseudo-ginseng, 16 parts of black nightshade, bittersweet 16
Part, 16 parts of indigo naturalis, 16 parts of calomel mercurous chloride.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710997054.3A CN107582984A (en) | 2017-10-20 | 2017-10-20 | A kind of pharmaceutical composition for treating cancer of the esophagus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710997054.3A CN107582984A (en) | 2017-10-20 | 2017-10-20 | A kind of pharmaceutical composition for treating cancer of the esophagus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107582984A true CN107582984A (en) | 2018-01-16 |
Family
ID=61043257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710997054.3A Pending CN107582984A (en) | 2017-10-20 | 2017-10-20 | A kind of pharmaceutical composition for treating cancer of the esophagus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107582984A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1333051A (en) * | 2001-06-29 | 2002-01-30 | 周伟 | Medicine for preventing and treating cancer and preparation process thereof |
-
2017
- 2017-10-20 CN CN201710997054.3A patent/CN107582984A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1333051A (en) * | 2001-06-29 | 2002-01-30 | 周伟 | Medicine for preventing and treating cancer and preparation process thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Li et al. | Anti-tumor potential of astragalus polysaccharides on breast cancer cell line mediated by macrophage activation | |
| Sasi et al. | Garlic (Allium sativum L.) bioactives and its role in alleviating oral pathologies | |
| He et al. | Using nano-selenium to combat Coronavirus Disease 2019 (COVID-19)? | |
| Alesci et al. | Can nutraceuticals assist treatment and improve covid-19 symptoms? | |
| Bell et al. | Mushrooms as future generation healthy foods | |
| Islam et al. | A review on measures to rejuvenate immune system: Natural mode of protection against coronavirus infection | |
| Panahi et al. | An updated review of natural products intended to prevent or treat oral mucositis in patients undergoing radio-chemotherapy | |
| Pan et al. | The latest progress of natural food polysaccharides preventing ulcerative colitis by regulating intestinal microbiota | |
| Xiong et al. | Okra pectin relieves inflammatory response and protects damaged intestinal barrier in caerulein‐induced acute pancreatic model | |
| Sauruk da Silva et al. | Beneficial effects of polysaccharides on the epithelial barrier function in intestinal mucositis | |
| CN107582984A (en) | A kind of pharmaceutical composition for treating cancer of the esophagus | |
| CN104547934A (en) | Medicine preparation for treating electric ophthalmia and preparation method thereof | |
| CN104523952A (en) | Chinese herbal medicine composition for treating chicken influenza | |
| CN104921109B (en) | A kind of antisenescence health product and its detection method | |
| CN107137572A (en) | A kind of eye drops and preparation method | |
| Das et al. | Antiviral activities of ginseng and its potential and putative benefits against monkeypox virus: A mini review | |
| CN101352560B (en) | Medicament for treating tumor | |
| CN105055428A (en) | Application of peroxy-ergosterol in preparation of medicament for treating primary liver cancer | |
| Lu et al. | Polysaccharides from the aerial parts of Tetrastigma hemsleyanum Diels et Gilg induce bidirectional immunity and ameliorate LPS-induced acute respiratory distress syndrome in mice | |
| Shirani et al. | Review on selected potential nutritional intervention for treatment and prevention of viral infections: possibility of recommending these for Coronavirus 2019 | |
| Jean Baptiste et al. | Anti-cancer Immune-modulatory Activities of Panax Genus Extracts and Bioactive Compounds | |
| TW201800099A (en) | The pharmaceutical composition for decreasing the side effects of cancer drug, and manufacturing method and uses thereof | |
| CN103041120A (en) | Pharmaceutical composition for controlling chicken infectious bursal disease and preparation method thereof | |
| Chen et al. | Plant-derived nanovesicles: harnessing nature's power for tissue protection and repair | |
| Li et al. | Application of natural polysaccharides and their novel dosage forms in gynecological cancers: therapeutic implications from the diversity potential of natural compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180116 |